443 related articles for article (PubMed ID: 21991606)
1. Trial clouds use of niacin with a statin.
Harv Heart Lett; 2011 Aug; 21(12):2. PubMed ID: 21991606
[No Abstract] [Full Text] [Related]
2. The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: baseline characteristics of study participants. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: impact on Global Health outcomes (AIM-HIGH) trial.
AIM-HIGH Investigators
Am Heart J; 2011 Mar; 161(3):538-43. PubMed ID: 21392609
[TBL] [Abstract][Full Text] [Related]
3. Statin therapy with ezetimibe or niacin in high-risk patients.
Kastelein JJ; Bots ML
N Engl J Med; 2009 Nov; 361(22):2180-3. PubMed ID: 19915218
[No Abstract] [Full Text] [Related]
4. Insights from recent meta-analysis: role of high-density lipoprotein cholesterol in reducing cardiovascular events and rates of atherosclerotic disease progression.
Negi S; Ballantyne CM
J Clin Lipidol; 2010; 4(5):365-70. PubMed ID: 21122680
[TBL] [Abstract][Full Text] [Related]
5. The facts behind niacin.
Hochholzer W; Berg DD; Giugliano RP
Ther Adv Cardiovasc Dis; 2011 Oct; 5(5):227-40. PubMed ID: 21893559
[TBL] [Abstract][Full Text] [Related]
6. What does the future hold for niacin as a treatment for hyperlipidaemia and cardiovascular disease?
Ahmed MH
J Cardiovasc Med (Hagerstown); 2010 Nov; 11(11):858-60. PubMed ID: 20686417
[TBL] [Abstract][Full Text] [Related]
7. The HALTS trial--halting atherosclerosis or halted too early?
Blumenthal RS; Michos ED
N Engl J Med; 2009 Nov; 361(22):2178-80. PubMed ID: 19915216
[No Abstract] [Full Text] [Related]
8. Cardiovascular primary prevention: how high should we set the bar?
Prasad V; Vandross A
Arch Intern Med; 2012 Apr; 172(8):656-9; discussion 659. PubMed ID: 22529231
[TBL] [Abstract][Full Text] [Related]
9. ARBITER-2 : evidence that targeting HDL cholesterol slows atherosclerosis.
Cardiovasc J S Afr; 2005; 16(1):61. PubMed ID: 15778778
[No Abstract] [Full Text] [Related]
10. Antioxidants blunt high-density lipoprotein response to statin plus niacin therapy.
Kris-Etherton PM
Curr Atheroscler Rep; 2001 Nov; 3(6):435-6. PubMed ID: 11602062
[No Abstract] [Full Text] [Related]
11. [Nicotinic acid and the derivative].
Ogaki S; Matsushima T
Nihon Rinsho; 2001 Mar; 59 Suppl 3():637-41. PubMed ID: 11347146
[No Abstract] [Full Text] [Related]
12. [Statin and absorption inhibitor work synergistically. More risk patient reach LDL cholesterol goal value].
MMW Fortschr Med; 2007 Apr; 149(17):56-7. PubMed ID: 17674912
[No Abstract] [Full Text] [Related]
13. Therapy and clinical trials.
Elmallah W; Krasuski RA
Curr Opin Lipidol; 2011 Dec; 22(6):512-3. PubMed ID: 22101564
[No Abstract] [Full Text] [Related]
14. I have had trouble controlling my cholesterol with a statin alone. Should I consider prescription niacin?
Johns Hopkins Med Lett Health After 50; 2010 Feb; 21(12):8. PubMed ID: 20344817
[No Abstract] [Full Text] [Related]
15. Termination of Atherothrombosis Intervention in Metabolic Syndrome with Low High-Density Lipoprotein Cholesterol and High Triglycerides: Impact on Global Health Study and decision to use extended-release niacin in elderly.
Shil AB
J Am Geriatr Soc; 2011 Dec; 59(12):2397-8. PubMed ID: 22188098
[No Abstract] [Full Text] [Related]
16. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
[TBL] [Abstract][Full Text] [Related]
17. Targeting cardiovascular risk associated with both low density and high density lipoproteins using statin-niacin combination therapy.
Duvall WL; Blazing MA; Saxena S; Guyton JR
J Cardiovasc Risk; 2002 Dec; 9(6):339-47. PubMed ID: 12478203
[TBL] [Abstract][Full Text] [Related]
18. LDL-Cholesterol is the King.
Goumas GS
Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
[No Abstract] [Full Text] [Related]
19. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K
Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310
[TBL] [Abstract][Full Text] [Related]
20. Dyslipidaemia: cardiovascular prevention--end of the road for niacin?
Tuteja S; Rader DJ
Nat Rev Endocrinol; 2014 Nov; 10(11):646-7. PubMed ID: 25178730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
